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by Receptor Uncoupling from the Cytoskeleton but Attenuated by
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Anders Højgaard Hansen,b Sunil K. Pandey,b Trond Ulven,b Huamei Forsman,a Claes Dahlgrena
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Swedena; University of
Southern Denmark, Odense, Denmarkb; Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg,
Gothenburg, Swedenc
Ligands with improved potency and selectivity for free fatty acid receptor 2 (FFA2R) have become available, and we here charac-
terize the neutrophil responses induced by one such agonist (Cmp1) and one antagonist (CATPB). Cmp1 triggered an increase in
the cytosolic concentration of Ca2, and the neutrophils were then desensitized to Cmp1 and to acetate, a naturally occurring
FFA2R agonist. The antagonist CATPB selectively inhibited responses induced by Cmp1 or acetate. The activated FFA2R in-
duced superoxide anion secretion at a low level in naive blood neutrophils. This response was largely increased by tumor necro-
sis factor alpha (TNF-) in a process associated with a recruitment of easily mobilizable granules, but neutrophils recruited to an
aseptic inflammation in vivowere nonresponding. Superoxide production induced by Cmp1 was increased in latrunculin A-
treated neutrophils, but no reactivation of desensitized FFA2R was induced by this drug, suggesting that the cytoskeleton is not
directly involved in terminating the response. The functional and regulatory differences between the receptors that recognize
short-chain fatty acids and formylated peptides, respectively, imply different roles of these receptors in the orchestration of in-
flammation and confirm the usefulness of a selective FFA2R agonist and antagonist as tools for the exploration of the precise role
of the FFA2R.
Induction of an inflammatory reaction occurs when healthy tis-sues are traumatized or infected by microbial pathogens (1, 2).
The inflammatory response is initially characterized by recruit-
ment and accumulation of phagocytic effector cells, mainly neu-
trophil granulocytes and monocytes, in the affected tissue. At the
inflamed site, the primary functions of these cells are to kill invad-
ing microbes, clear the tissue of debris, and initiate the resolution
phase (1). Although inflammation is vital in tissue repair and
eradication of pathogens, an unresolved inflammatory response
and inappropriate cellular activation can be detrimental to the
host (3). Knowing the precise mechanisms underlying phagocyte
function under normal healthy conditions is thus fundamental
and crucial for our understanding of pathological immune reac-
tivity in disease.
The inflammatory response is normally initiated and main-
tained and sometimes modulated by a number of microbial or
host-derived pathogen- anddanger-associatedmolecular patterns
(PAMPs and DAMPs) (4–6), and it is clear that these DAMPs and
PAMPs together participate in amultistep hierarchy of directional
cues that regulate neutrophil function at inflammatory sites (7, 8).
Formyl peptides, hallmarks of bacterial protein synthesis (9), exert
their functions through pattern recognition receptors (PRRs)
known as the formyl peptide receptors (FPRs), a group of recep-
tors that belong to the family of G-protein-coupled receptors
(GPCRs). The FPRs are expressed primarily in inflammatory or
innate immune cells such as neutrophils (expressing FPR1 and
FPR2) and monocytes (expressing also FPR3 [10–12]). Short-
chain fatty acids (SCFAs) are also produced by bacteria and reach
very high concentration in the gut, where they constitute another
type of microbial pattern (13). The SCFAs are subsequently trans-
ported over the gut epithelium to be released in the bloodstream,
where theymay reachmillimolar concentrations. The SCFAs have
been shown to activate leukocytes, and two until fairly recently
orphan receptors, GPR41 and GPR43 (now known as free fatty
acid receptor 3R [FFA3R] and FFA2R, respectively), have been
identified as fatty acid-recognizing receptors (14). These two re-
ceptors also belong to the family of GPCRs, and one of these,
FFA2R, is highly expressed in neutrophils; published data suggest
that the receptor has important roles in orchestration of inflam-
matory reactions (15), and on that basis, it is of interest as a drug
target (16). A proper and defined regulatory role for FFA2R in
neutrophil function has not been possible to disclose, due to the
lack of potent and selective agonists and antagonists. Given the
fact that novel selective ligands, both orthosteric FFA2R agonists
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and antagonists, were recently described (17, 18), this situation is
now about to change.
We have determined the basic activation and inhibition prop-
erties in relation to human neutrophils of Cmp1 and CATPB (see
below), two recently described FFA2R ligands (17, 18). The new
FFA2R ligands were initially characterized through the desensiti-
zation and inhibition profiles of the neutrophil response (tran-
sient increase in cytosolic Ca2) to acetate, and we show that
Cmp1 is a selective FFA2R agonist and CATPB is a potent antag-
onist for the same neutrophil receptor. The potency of Cmp1 to
induce reactive oxygen species (ROS) production in naive neutro-
phils was low, but the production was significantly increased in
cells first primed with tumor necrosis factor alpha (TNF-) or
latrunculin A. We also show that neutrophils isolated from an
aseptic inflammation are nonresponders to Cmp1, suggesting a
role for FFA2R in the recruitment process.
MATERIALS AND METHODS
Chemicals. Isoluminol, TNF-, and latrunculin A were obtained from
Sigma Chemical Co. (St. Louis, MO). Cyclosporin H (CysH) was a kind
gift provided by Novartis Pharma (Basel, Switzerland). Dextran and Fi-
coll-Paque were obtained from GE-Healthcare Bio-Science (Uppsala,
Sweden). Fura-2 was from Molecular Probes/Thermo Fisher Scientific
(Waltham, MA), and horseradish peroxidase (HRP) was obtained from
Boehringer Mannheim (Germany). Peptides were dissolved in dimethyl
sulfoxide (DMSO) and stored at70°C until use. Subsequent dilutions of
all peptides and other reagents were made in Krebs-Ringer glucose phos-
phate buffer (KRG; 120 mM NaCl, 4.9 mM KCl, 1.7 mM KH2PO4, 8.3
mM NaH2PO4, 1.2 mM MgSO4, 10 mM glucose, and 1 mM CaCl2 in
distilled water [dH2O] [pH 7.3]). Ammonium acetate (NH4OAc) was
from Merck (Germany).
The FFA2R agonist Cmp1 [3-benzyl-4-(cyclopropyl-(4-(2,5-di-
chlorophenyl)thiazol-2-yl)amino)-4-oxobutanoic acid] and the an-
tagonist CATPB [(S)-3-(2-(3-chlorophenyl)acetamido)-4-(4-(trif-
luoromethyl)phenyl) butanoic acid] were synthesized as described
previously (17, 19, 20).
The FPR2-specific hexapeptide WKYMVM and the FPR1-specific
peptides fMLF and fMIFL were synthesized and high-performance liquid
chromatography (HPLC) purified by TAG Copenhagen A/S (Copenha-
gen, Denmark). The two formylated peptides are full FPR1 agonists that
can be used interchangeably as control agonists specific for this receptor;
the 50% effective concentrations (EC50s) in our neutrophil NADPH oxi-
dase assay system (see below) were 1 and 50 nM for fMIFL and fMLF,
respectively (21, 22).
FIG 1 Chemical structures of the compounds Cmp1 (A) and CATPB (B) used
to characterize FFA2R-triggered responses in human neutrophils.
FIG 2 Transient intracellular Ca2 response in neutrophils triggered by Cmp1 and acetate. (A and B) Neutrophils loaded with Fura-2 were stimulated with
Cmp1 (A) or acetate (B). The timepoint for addition of an agonist is indicated by an arrow. The increase in intracellular [Ca2]i, given by the ratio between Fura-2
fluorescence at 340 and 380 nm, is shown. (C) Dose-response curves of Cmp1- and acetate-induced rises in intracellular Ca2 in neutrophils. Abscissa,
concentration of agonist (log M); ordinate, peak response as percentage of the maximum induced response ratio (mean SEM; n 3).
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Neutrophil isolation from blood and tissue. Blood neutrophils were
isolated from heparinized whole blood or buffy coats from healthy blood
donors by dextran sedimentation and Ficoll-Paque gradient centrifuga-
tion as described by Bøyum et al. (23). Remaining erythrocytes were re-
moved by hypotonic lysis, and the neutrophils were washed twice and
resuspended in KRG and stored on ice until use.
In vivo-transmigrated neutrophils were obtained from skin chambers;
details on themethodology are given in reference 24. Briefly, blisters were
formed on the forearms of healthy volunteers by negative pressure for 2 h.
The blister roofs were removed, and autologous serum was added to col-
lection chambers that were sealed and left for 24 h. The chamber fluid
containing neutrophils was then collected, and the cells were pelleted and
stored in KRG on ice until use. Blood neutrophils were isolated from the
same subjects on the day of collection.
Measuring NADPH oxidase activity. Isoluminol-enhanced chemi-
luminescence (CL) was used to measure superoxide production, the
precursor of production of reactive oxygen species (ROS), by the
NADPH oxidase activity as described previously (25, 26). In short,
the CLmeasurements were performed in a six-channel Biolumat LB 9505
(Berthold Co., Wildbad, Germany), using disposable 4-ml polypropylene
tubes and a 900-l reactionmixture containing 105 cells, isoluminol (2
105 M), and HRP (4 U). The tubes were equilibrated for 5 min at 37°C
before addition of an agonist (100l), and the light emissionwas recorded
continuously. To study desensitization and reactivation of a receptor,
naive (nondesensitized) cells were stimulated with the receptor-specific
agonist andwhen the response triggeredwas terminated (usually in 5 to 10
min), a new agonist binding to the same receptor (desensitization) or
actin-disrupting agent latrunculin A (reactivation) was added. In experi-
ments in which the effects of receptor-specific antagonists were deter-
mined, these were added to the reaction mixture 1 to 5 min before stim-
ulation. Control cells incubated under the same condition but receiving
no antagonist were used in parallel.
Calcium mobilization. Neutrophils at a density of 1  106 to 3 
106/ml were washed with Ca2-free KRG and centrifuged at 220 g. The
cell pellets were resuspended at a density of 2  107 cells/ml in KRG
containing 0.1% bovine serum albumin (BSA) and loaded with 2 M
Fura-2-AM for 30 min at room temperature. The cells were then diluted
to twice the original volume with RPMI 1640 culture medium without
phenol red (PAA Laboratories GmbH, Pasching, Austria) and centri-
fuged. Finally, the cells were washed once with KRG and resuspended in
the same buffer at a density of 2 107/ml. Calcium measurements were
carried out in a PerkinElmer fluorescence spectrophotometer (LC50),
with excitation wavelengths of 340 nm and 380 nm, an emission wave-
length of 509 nm, and slit widths of 5 nm and 10 nm, respectively. The
transient rise in intracellular calcium is presented as the ratio of fluores-
cence intensities (340 nm to 380 nm) detected.
A change in intracellular Ca2 was also measured using flow cytom-
etry with mixed leukocytes as described previously (27). In short, mixed
leukocyte populations were loaded with the Ca2 indicator dyes Fluo-3
(Molecular Probes; fluorescence increases upon Ca2 binding) and Fura-
Red (Molecular Probes; fluorescence decreases upon Ca2 binding).
Fluo-3 and FuraRed intensity was recorded continuously using an Accuri
C6 flow cytometer (BD Accuri), and stimuli were added as indicated be-
low. Analysis was performed using FlowJo software (v. 7.6.5; TreeStar),
and results are presented as the ratio between Fluo-3 and FuraRed (nor-
malized against the value at time zero), reflecting the relative cytosolic
Ca2 concentration, over time.
Cell surface receptor expression. The level of surface expression of
the integrin complement receptor 3 (CR3) was determined by the use of a
phycoerythrin (PE)-conjugated antibody against CR3 (BD Biosciences,
FIG 3 Cross desensitization between Cmp1 and acetate and sensitivity to EGTA of the increase in [Ca2]i. (A) Neutrophils first activated with Cmp1 (upper
curve; 1M)were challenged with acetate (10 mM), and neutrophils first activated with acetate (lower curve; 10 mM) were challenged with Cmp1 (1M). The
time point for addition of an agonist is indicated by an arrow. The increase in intracellular [Ca2]i is given by the ratio between Fura-2 fluorescence at 340 and
380 nm, and the bar represents a ratio value of 0.5. AU, arbitrary unit. (B) Neutrophils first activated with Cmp1 (1M) were challenged with fMIFL (1 nM); as
a control, the curve for neutrophils challenged with fMIFL (1 nM) alone is also shown (bottom). The time point for addition of an agonist is indicated by an
arrow. The increase in intracellular [Ca2]i is given by the ratio between Fura-2 fluorescence at 340 and 380 nm, and the bar represents a ratio value of 0.5. (C)
Neutrophils were activatedwith acetate (upper curves; 10mM) andCmp1 (lower curves; 1M) in the absence or presence EGTA (added 20 s prior to the agonists
to a final concentration of 5 mM). The time point for addition of an agonist is indicated by an arrow. The increase in intracellular [Ca2]i is given by the ratio
between Fura-2 fluorescence at 340 and 380 nm, and the bar represents a ratio value of 0.5.
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MD). To surface label the polymorphonuclear leukocytes (PMNs), cells in
KRG (5 106/ml) were incubated on ice, the antibodies were added, and
the incubationwas prolonged for 30min. Control samples incubatedwith
isotype control antibodies were included. After a washing step to remove
excess unbound antibodies, the amount of bound fluorescence was deter-
mined by flow cytometry using an Accuri C6 flow cytometer (Becton
Dickinson, Sparks, MD).
Chemotaxis assay.Neutrophil migration was determined using a 96-
well microplate chemotaxis chambers with hydrophobic filters with a
pore size of 3 m (ChemoTx; Neuro Probe Inc., Gaithersburg, MD) ac-
cording to the instructions given by the manufacturer. In short, Cmp1 at
various concentrations was added to wells in the lower chamber. All dilu-
tions were made in KRG supplemented with 0.3% BSA. Naive or TNF--
primed neutrophils (30 l; 106/ml) were placed on top of the filters and
allowed tomigrate for 90min at 37°C. Cellmigrationwas examined under
a microscope. For quantification, the content of myeloperoxidase was
assessed in the lysates of transmigrated cells by adding the peroxidase
substrate o-phenylenediamine.
Data collection and statistical analysis.Data were collected from in-
dividual blood donors and processed using GraphPad Prism. One-way
analysis of variance (ANOVA) was used for statistical analysis. Significant
differences are indicated in the figures.
RESULTS
Cmp1activates the phospholipaseC-inositol phosphate 3 (IP3)-
Ca2 signaling route in neutrophils and desensitizes the cells to
acetate. A molecule identified from the patent literature with re-
ported activity on free fatty acid receptor 2 (FFAR2) was recently
characterized as an orthosteric agonist for the human FFAR2/
GPR43 (17), and this compound, Cmp1 (structure shown in Fig.
1A), was used to investigate the basic functions of this receptor in
human neutrophils. FFA2R belongs to the family of G-protein-
coupled receptors (GPCRs), and one of the very early signals gen-
erated by many GPCR agonists in neutrophils is a rise in the cyto-
solic concentration of free Ca2 ([Ca2]i). Accordingly, naive
neutrophils responded dose dependently by transient increases in
[Ca2]i to both Cmp1 (Fig. 2A) and to one of the known natural
agonists for FFA2R, acetate (Fig. 2B). As expected, Cmp1 was
muchmore potent than acetate (EC50s of 640 nM for Cmp1 and 2
mM for acetate [Fig. 2C]). Neutrophils activated with Cmp1 were
homologously desensitized in their response to acetate, and the de-
sensitization protocolworked alsowhen the order of the FFA2R ago-
nists was reversed; i.e., neutrophils desensitized to acetate were non-
responsive toCmp1(Fig. 3A).TheCmp1-desensitizedcellswere fully
responsive to the formylated peptide fMIFL, a prototype agonist for
one of the formyl peptide receptors (FPR1) expressed in neutrophils
(Fig. 3B).
The very rapid rise in the cytosolic concentration of free
[Ca2]i induced in neutrophils is for many GPCR agonists
achieved through an emptying of intracellular Ca2 stores. A rise
in [Ca2]i originating from the stores should be largely insensitive
to the presence of EGTA, which chelates all extracellular free Ca2
and by that eliminates any contributions to the cytosolic rise in
[Ca2]i from an opening of store operated ion channels in the
plasma membrane. The transient increases in [Ca2]i induced by
FIG 4 No transient rise in intracellular Ca2 is induced by Cmp1 in human monocytes or lymphocytes. Mixed leukocyte populations were loaded with Fluo-3
and FuraRed and then stained using anti-CD45 antibodies to allow discrimination of leukocyte subsets during Ca2measurements by flow cytometry. The ratio
between the fluorescence intensities from the twoCa2 indicator dyes was recorded continuously during activation of lymphocytes,monocytes, and neutrophils.
Background Fluo-3/FuraRed intensity was recorded for 30 s, after which an agonist was added (indicated by arrows). The stimuli were Cmp1 (10M) and fMLF
(10 nM) as indicated. The diagrams show the normalized ratios between Fluo-3 and FuraRed fluorescence intensities, reflecting relative cytosolic Ca2 levels over
time in the indicated cell populations, and data are representative of the results of 3 independent experiments. The dot plot shows the gates used for the different
cell types. SSC, side scatter; FSC, forward scatter.
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Cmp1 and also by acetate were basically left unchanged in the
presence of EGTA (Fig. 3C).
Most GPCRs present in neutrophils are expressed also in
monocytes, and to determine if this was valid also for a functional
FFA2R, the Cmp1-induced rise in [Ca2]i was determined in a
mixed leukocyte preparation. In agreement with the results de-
scribed above, neutrophils responded to Cmp1 by transient in-
creases in [Ca2]i, but no such change was induced in monocytes
or lymphocytes (Fig. 4). The response induced in neutrophils and
monocytes by the FPR1-specific agonist fMLF is shown for com-
parison (Fig. 4). The monocytes remained nonresponders to
Cmp1 also in cells that were first primed with TNF- (see Fig. S1
in the supplemental material).
The novel FFA2R antagonist CATPB inhibits the transient
rise in intracellular Ca2 induced in neutrophils by acetate or
Cmp1. In addition to a potent agonist, a selective inhibitor for
FFA2R would be equally useful in defining the basic functions
triggered through this receptor, and one such antagonist, or
rather, inverse agonist, CATPB (structure shown in Fig. 1B), has
been described previously (20). This novel inhibitor, selective for
the human FFA2R, was used to further characterize receptor-spe-
cific events. No direct [Ca2]i change was induced in neutrophils
by CATPB alone, but the presence of CATPB dose dependently
inhibited the transient increase in [Ca2]i induced by Cmp1 (Fig.
5A) or acetate (Fig. 5B). In addition, there was no effect of CATPB
on the response induced by the FPR1 agonist fMLF (Fig. 5C), and
likewise, there was no effect of the FPR1-selective antagonist (cy-
closporin H) on the Cmp1-induced neutrophil response (see Fig.
S2A in the supplemental material). The inhibitor/inverse agonist
was fairly potent, as full inhibition of the Cmp1-induced response
was achieved with a molar ratio of 0.1 between the inhibitor
CATPB and the Cmp1 agonist (Fig. 5A).
Taken together, these data show that Cmp1 is a potent FFA2R
agonist and CATPB is a potent and selective inhibitor/antagonist
for the same receptor.
A low degree of mobilization of neutrophil secretory organ-
elles and no chemotaxis were induced by Cmp1. Cmp1 at 1 M
induced a maximal rise in [Ca2]i, but this concentration trig-
gered a fairly low level of granule secretion as measured by an
increased exposure of complement receptor 3 (CR3), a receptor
stored in easily mobilized neutrophil organelles (Fig. 6A). In ad-
dition, Cmp1 was unable to cleave the neutrophil activation
marker L-selectin from the cell surface (Fig. 6B). In contrast, L-
selectin was cleaved off from the cell surface of the positive-con-
trol cells treated with TNF-, and surface CR3 was also upregu-
lated by the cytokine (Fig. 6A and B). Taken together, the results
show that Cmp1, like most neutrophil chemoattractant GPCR
agonists, induces a rise in [Ca2]i, but despite this it is not a potent
secretagogue. In addition, the chemotactic activity of Cmp1 was
examined (Fig. 6C). We used a classic Boyden filter technique but
could not detect any increased migration over the buffer control
values when Cmp1 was present in the lower compartment of the
chambers (Fig. 6C). The neutrophils remained nonresponders to
FIG 5 The antagonist CATPB inhibits the transient rise in intracellular Ca2 in neutrophils triggered by Cmp1 and acetate. (A and B) Neutrophils loaded with
Fura-2 were stimulated with Cmp1 (A; 1M), or acetate (B; 10mM) in the absence or presence of different concentrations of CATPB (6.25 nM to 100 nM). The
rise in intracellular Ca2 was determined following addition of an agonist (time point indicated by an arrow). Abscissa, time scale; ordinate, [Ca2]i increase
given by the ratio between Fura-2 fluorescence at 340 and 380 nm; the bar represents a ratio value of 1.0. (C)Neutrophils loadedwith Fura-2were stimulatedwith
Cmp1 (1 M), acetate (10 mM), or fMFL (10 nM) in the absence or presence of CATPB (500 nM). The rise in intracellular Ca2 was determined, and the peak
activities were determined (mean SEM; n 3). ****, P	 0.0001; ns, no significance.
Neutrophil Free Fatty Acid Receptor 2
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Cmp1 in the chemotaxis assay also when cells were first primed
with TNF- (see Fig. S3 in the supplemental material).
TNF- primed the Cmp1-triggered activation of the neutro-
phil NADPH oxidase.Neutrophils are equipped with an enzyme
system that at the expense of NADPH reduces molecular oxygen
to superoxide, and when activated, this system gives rise to a mi-
tochondrion-independent respiratory burst (28). Classical neu-
trophil chemoattractants activate the neutrophilNADPHoxidase,
and reactive oxygenmetabolites are secreted (29). The two FFA2R
ligands were used to determine the relation between this receptor
and the neutrophil superoxide-generating oxidase. We show that
also the FFA2R agonist Cmp1 activates the NADPH oxidase to
produce superoxide and the activity was concentration depen-
dent, with an EC50 of 1 to 2 M and a maximum response ob-
tained with around a 5Mconcentration of the agonist (Fig. 7A).
The time course of the response induced was very similar to that
induced by the FPR1 agonist fMIFL (a rapid onset and a peak of
the activity reached after around 45 s [Fig. 7A, inset]), but the
efficacy of Cmp1 was low compared to that of the FPR1 agonist
(peak ratio value fMIFL/Cmp1
 10 [Fig. 7A and inset]).
No NADPH oxidase assembly and activation was obtained
when neutrophils in suspensionwere challengedwith TNF-, and
this is in agreement with results reported earlier (30–32). How-
ever, TNF- primed the neutrophils in their response to fMIFL
(an FPR1 agonist) (Fig. 7B, inset), WKYMVM (an FPR2 agonist),
PAF (an agonist for the PAFR) (31, 33), andCmp1. As recorded by
an increased release of superoxide, Cmp1was turned into a potent
activator of the NADPH-oxidase in TNF--primed neutrophils
(Fig. 7B).
TNF- induces a mobilization of receptor-storing granules
without any transient increase in [Ca2]i. As shown in Fig. 7B,
neutrophils were primed in their response to Cmp1 by the cyto-
kine TNF-, the primed neutrophils produced at least 5 times
(measured as peak values) more superoxide anions than did naive
neutrophils, and the production reached levels comparable to that
induced by fMLF. Previous studies have shown thatmany neutro-
phil receptors, including FPR1 and FPR2, are stored in secretory
organelles of naive cells (34–36), and mobilization of FPRs to the
cell surface is accompanied with a primed FPR response, suggest-
ing a possible role for granule mobilization in mediating priming.
We show that neutrophils treated with TNF- exposed an in-
creased number of the CR3 (Fig. 6A); i.e., integrin-storing organ-
elles have been mobilized, and thus, receptor mobilization could
serve to explain the increased oxidative response in primed cells.
Marker analyses of secreted material suggest that TNF- is a
secretagogue both for the gelatinase granules (marker MMP9)
and, to some extent, for the specific granules (marker NGAL).
No release of MPO, a marker for the azurophil granules, was
obtained (Fig. 8A).
An increase in [Ca2]i alone is sufficient to trigger fusion be-
FIG 6 Neutrophil activation byCmp1 determined as CR3mobilization and L-selectin cleavage from the cell surface and induction of chemotacticmigration. (A)
Neutrophils were stimulated with TNF- (10 ng/ml) or Cmp1 at different concentrations or left without any agonist (control/resting cells) for 10 min at 37°C,
and the surface expression of CR3was determined by fluorescence-activated cell sorting (FACS) analysis. The results are expressed in percent increase of the CR3
expression compared to the value in control cells (mean  SEM; n  3). (B) Neutrophils were stimulated with TNF- (10 ng/ml) or Cmp1 at different
concentrations or left without any agonist for 10min at 37°C, and the surface expression of L-selectin was determined by FACS analysis. The results are expressed
in percentage of the L-selectin cleaved off from the cell surface compared to amount present on control cells kept on ice (mean SEM; n 3). (C) Chemotaxis
induced in neutrophils by Cmp1 and the positive-control peptide fMLF (10 nM). Neutrophils were added on top of the filter that separated the upper
compartment containing cells but no agonist from the lower compartment containing the attractant. Themigration chambers were incubated at 37°C for 90min
and the fraction of cells (percentage of those added) in the lower compartments was determined. Data are expressed as mean migration  SEM of triplicate
samples obtained from three independent experiments. ***, P	 0.001; **, P	 0.01; *, P	 0.05; ns, no significance.
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tween neutrophil receptor-storing organelles and the plasma
membrane (37). The nexus between TNF--triggered responses
and the role of a transient cytosolic calcium increase has, however,
not been finally settled, as the cytokine has been shown to induce
different types of intracellular calcium responses in surface-ad-
herent neutrophils and cells in suspension (38–41).We found that
the TNF--triggeredmobilization of granule constituents in neu-
trophil suspensions occurred without any transient increase in
[Ca2]i (Fig. 8B). For comparison, we show the response induced
by the chemoattractant fMLF that induces a transient rise in in-
tracellular calcium (Fig. 8B).
Cmp1-induced NADPH oxidase activity was inhibited by
pertussis toxin and by the FFAR2 antagonist CATPB. To deter-
mine the sensitivity of FFA2R to pertussis toxin, neutrophils were
treated with the toxin, samples were removed after different du-
rations of incubation, and the ability of the cells to generate O2

was determinedwhen cells were challenged with Cmp1, fMIFL, or
a direct protein kinase C (PKC) activator (phorbol myristate ace-
tate [PMA]) that bypasses heterotrimeric G proteins. The ability
of the cells to respond to Cmp1 and fMIFL was gradually lost, and
after a 120- to 250-min incubation with pertussis toxin, the neu-
trophils were unresponsive to these agonists (shown for Cmp1 in
Fig. 9A), whereas only a small reduction was seen in the response
to PMA (Fig. 9A, inset).
Taken together, our data show that the neutrophil receptor
used by Cmp1 to activate the neutrophil NADPH oxidase is
FFA2R, and the signals generated are transferred by an activation
of Gi. The FFA2R antagonist CATPB by itself triggered no acti-
vation of the neutrophil NADPH oxidase, but the oxidase activi-
ties induced by Cmp1 in both naive (Fig. 9B, inset) and latruncu-
lin A-primed cells (see below) were largely inhibited by the
antagonist (Fig. 9B and C). CATPB inhibited also the response
induced by Cmp1 in TNF--primed neutrophils (Fig. 9C). In
agreement with the inhibition profile of the different receptor an-
tagonists on the rise in [Ca2]i (see above), CATPB inhibited the
Cmp1-induced response, whereas there was no effect on the re-
sponse triggered by an FPR agonist. In addition, there were no
effects of the specific FPR antagonist (CysH for FPR1) on the
Cmp1-induced response (see Fig. S4 in the supplemental mate-
rial). Similar to results obtained when monitoring [Ca2]i,
CATPB was a very potent inhibitor in that the Cmp1-induced
neutrophil activity was inhibited when the two were presented in
a molar ratio (CATPB/Cmp1) of around 0.1.
The Cmp1 molecule was replaced by acetate, and the results
obtained were basically the same, but the activity induced by the
short-chain fatty acid was of a lower magnitude and millimolar
concentrations were required for activation, with an EC50 for ac-
tivation of around 5 mM.
Terminationof theFFA2R-triggered response and role of the
cytoskeleton. It is well established that neutrophils generate and
secrete reactive oxygen species in response to many inflammatory
mediators that bind to receptors, such as the FPRs and C5aR, and
that this response is substantially increased and also prolonged
when agonist binding takes place in the presence of drugs which
inhibit actin polymerization (i.e., cytochalasin B or latrunculin A)
and by that disrupts the cytoskeleton. Accordingly, the response
induced by fMIFL was both prolonged and increased in neutro-
phils pretreated with latrunculin A (Fig. 10A), and a comparison
of themaximal responses reveals a ratio between peak values in the
presence and absence of latrunculin A, respectively, of 3 to 4.
When investigating the effect of latrunculin A as a priming agent
on the response induced in neutrophils activated with Cmp1 (Fig.
10B), it is clear that the effect was more dramatic and in the pres-
ence of the cytoskeleton-disrupting drug Cmp1 became very po-
tent in activating the NADPH oxidase. The level of superoxide
production induced by Cmp1 reached the same level as that trig-
gered by an FPR1 agonist (Fig. 11), and the ratio between the peak
values in the presence and absence of latrunculin Awas around 50
(Fig. 10B).
As mentioned, the response in neutrophils induced by FPR1
agonists measured as NADPH oxidase activity is very much pro-
longed in the presence of latrunculin A (Fig. 10A), suggesting a
role for an intact cytoskeleton in the termination of the response
induced by the FPR1 agonist. The kinetics of the Cmp1-induced
activity in latrunculin A-treated neutrophils is very similar to that
induced by the FPR1 agonist in the absence of the drug. This
suggests that the responses induced by the two receptors are ter-
minated by differentmechanisms. Earlier studies have shown that
the agonist-occupied FPR1 rapidly becomes desensitized, and this
is achieved through a binding of the receptor-ligand complex to
the cytoskeleton, a process that leads to a lateral segregation of the
FIG 7 Neutrophil activation by Cmp1 determined as neutrophil superoxide
production. (A)Humanneutrophils were activatedwithCmp1 (different con-
centrations as indicated) or fMIFL (1 nM; inset), and superoxide production
was recorded continuously. The time point for addition of an agonist is indi-
cated by an arrow. Mcpm is an arbitrary unit. (B) Nonprimed and TNF--
primed (20 min at 37°C with 10 ng/ml of the cytokine) human neutrophils
were activated with Cmp1 (2 M) or fMIFL (1 nM, inset), and superoxide
productionwas recorded continuously. The time point for addition an agonist
is indicated by an arrow.
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occupied receptor from the signaling heterotrimeric G-protein.
Accordingly, the prolongation of the FPR1-induced response in
the presence of cytoskeleton-disrupting drugs is due to an inabil-
ity of the disrupted cytoskeleton to bind the receptor-ligand com-
plex and terminate signaling. Neutrophils activatedwith FPR ago-
nists become after a short period of active signaling (measured as
superoxide production) desensitized to a new dose of the same
attractant (42), but the desensitized FPR1 is reactivated by latrun-
culinA, as shownby the robust burst of oxidase activity induced in
desensitized cells when the cytoskeleton is disrupted (Fig. 10C).
This response is triggered through FPR1, which is clear from the
fact that cyclosporin H totally inhibits the activity (43). We have
now determined the effect of latrunculin A as a receptor uncou-
pler on cells desensitized to Cmp1. A very low level of NADPH
oxidase activity was induced in these cells when latrunculin A was
added (Fig. 10C), but the cells were fully responsive to an FPR1
agonist (see Fig. S5A in the supplementalmaterial). The timewin-
dow in relation to Cmp1 addition between achieving full activity
and no activity upon addition of latrunculin A is fairly narrow;
addition of latrunculin A 1 min prior to the addition of Cmp1 is
sufficient to obtain full receptor activity, whereas a gradually lower
activity is obtained when latrunculin A is added at later time
points (see Fig. S5B). In contrast, the desensitized FPR1 is fully
reactivated also when latrunculin A is added 20 min after the ag-
onist.
Skin chamber neutrophils are low responders to Cmp1. In
vivo-transmigrated neutrophils were obtained from skin cham-
bers, allowing us to determine to what extent a modulation of the
response to Cmp1 occurs during the recruitment process in vivo.
The process ofmigration fromblood to tissue renders neutrophils
primed in their response to some agonists and desensitized to
others (24). The skin chamber neutrophils migrate toward an
aseptic, acute inflammation in an otherwise healthy tissue, and a
primed response achieved through extravasation may be a regu-
latory mechanism, granting a cellular response (such as release of
toxic oxygen radicals) only at sites where it is functional and nec-
essary, e.g., in inflamed or infected areas, but indicates also that
natural agonists for such a receptor are not used as attractants.We
now confirm earlier findings (24) by showing that the response
induced in skin chamber neutrophils by an FPR1 agonist was
primed (shownwith fMIFL in Fig. 11A), but in contrast to this, we
show that the response induced in in vivo-transmigrated neutro-
phils by Cmp1 was largely attenuated (shown with latrunculin
A-treated cells in Fig. 11B).
DISCUSSION
There has been an urgent need for synthetic receptor-specific li-
gands to allow studies of FFA2R in neutrophils. The recently de-
scribed Cmp1 and CATPB molecules fulfill the requirements in
being both fairly potent and receptor selective (17, 20). The ex-
pression and basic functional characteristics of FFA2R in phago-
cytic cells were describedwhen the receptorwas deorphanized and
shown to be predominantly expressed in peripheral blood leuko-
cytes and recognize short-chain free fatty acids (44, 45). Using
Cmp1, we now confirm some of the original findings stating that
the agonist occupied FFA2Rs activate neutrophils through a sig-
naling cascade that involves a pertussis toxin-sensitive G-protein
and the IP3 route to induce a release of Ca
2 from intracellular
FIG 8 TNF- triggers granule secretion without Ca2 signaling in neutrophils. (A) Neutrophils were incubated for 10 min at 37°C with TNF- (10 ng/ml) or
fMLF (10 or 100 nM). The cells were removed by centrifugation, and the amounts of enzyme present in the cell free supernatants were determined. The values
are means (SEM; n 3) and expressed as percentages of the total (Triton X-100-treated cells). (B) Neutrophils loaded with Fura-2 were stimulated with fMLF
(10 or 100 nM) or TNF- (25 ng/ml). The time point for addition of an agonist is indicated by an arrow. The increase in intracellular [Ca2]i is given by the ratio
between Fura-2 fluorescence at 340 and 380 nm.
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storage organelles, responses similar to the characteristics of the
fairly well-characterized receptor for formylated methionyl con-
taining peptides (FPR1). We also add some new molecular in-
sights into regulatory mechanisms of FFA2R activation and ter-
mination anddisclose both similarities to anddifferences from the
FPRs. It is clear that although Cmp1 induces a rise in intracellular
Ca2 in neutrophils, this response is not accompanied by any
mobilization of CR3 to the cell surface or cleavage of L-selectin
from the cell surface. The main storage pool for the 2-integrin
CR3 is the easily mobilized secretory granules, the most readily
mobilized neutrophil vesicles/granules (37). The increased expo-
sure of CR3 together with the shedding of L-selectin are the two
most sensitive neutrophil markers for activation, a process that
constitutes the basis for how neutrophils grade their response to
chemoattractants and allow them to leave the bloodstream and
enter an inflamed tissue. In agreement with the low degree of
neutrophil activation induced by FFA2R agonist, no chemotactic
activity was induced by Cmp1.
Activation of neutrophils with the FFA2R agonist Cmp1 in-
duced an assembly of the superoxide-generatingNADPHoxidase.
The degree of activation was, however, fairly low, but TNF- pro-
nouncedly primed the response. Although extensively studied, the
precise mechanism underlying priming of the NADPH oxidase
response has not been clarified. The fact that pretreatment with
TNF- induced mobilization of neutrophil organelles suggests a
role for this process in priming (35, 46), and it is clear that the
priming effect of TNF- is evident also with other stimuli, for
which a mobilization of receptor-storing organelles might be part
of the primingmechanism (35, 47). It has also been suggested that
the profiles of the neutrophil subcellular proteomemay be used as
a base to predict the subcellular localization of different protein,
but despite the fact neutrophils express functional receptors, for
example, for TNF- and FFA2R, these receptors do not show up
in such a subcellular proteome (48). Moreover, the receptor for
the lipid chemoattractant PAF is expressed exclusively in the
plasma membrane (33), and despite this, TNF- also primes the
PAF-induced neutrophil response (33). Priming may thus be
achieved without receptor mobilization; additional suggested
mechanisms include increased membrane expression or translo-
cation of NADPH oxidase components (49), alterations of intra-
cellular signaling pathways, increased protein phosphorylation
(50), phospholipase activity (51), intracellular Ca2 changes (52),
cross talk between Ca2 increase and tyrosine phosphorylation
(53), altered assembly of the oxidase (54), and proteolytic process-
ing of cell surface proteins (55). Multiple mechanisms may be
involved in TNF--induced priming, and since no antibody is
available that recognizes surface-expressed FFA2Rs, it is not pos-
sible to conclusively determine the degree of mobilization of the
FFA2R during priming. Although the precise mechanism is un-
known, it is interesting to note that TNF- recruits receptors from
easily mobilizable granules/vesicles to the neutrophil cell surface
without any transient rise in intracellular calcium, whereas Cmp1
FIG 9 Cmp1-induced neutrophil production of superoxide anions is inhibited by pertussis toxin (PTX) and the FFA2R antagonist CATPB. (A) Human
neutrophils incubated with pertussis toxin (500 ng/ml) for 120 min were activated with Cmp1 (2 M) or PMA (50 nM; inset), and superoxide production was
recorded continuously in the presence of latrunculin A (25 ng/ml). Results of a representative experiment are shown. The time point for addition of the agonist
is indicated by an arrow. (B) Neutrophils without any additive (inset) or with latrunculin A (25 ng/ml) were activated with Cmp1 (2 M) in the presence or
absence of CATPB (1M), and superoxide productionwas recorded continuously. Results of a representative experiment are shown. The time point for addition
of the agonist is indicated by an arrow. (C) Inhibition by CATPB (500 nM) of the response induced by Cmp1 (2 M) in neutrophils primed with TNF- (10
ng/ml; 20 min) or latrunculin A (25 ng/ml; 5 min). The neutrophil response was measured as superoxide production that was recorded continuously. The peak
activities were determined, and the results are expressed as percent activity remaining in the presence of the antagonist compared to the value for control
neutrophils without any antagonist (mean SEM; n 3). ****, P	 0.0001.
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is a weak secretagogue despite its capacity to induce a transient rise
in [Ca2]i. These data raise questions that we at present only can
speculate upon, and these include the mechanisms for priming of
the FFA2R mediated response by TNF- and the precise role of
calcium in granule mobilization.
It is clear that the easily mobilized neutrophil organelles and
their content of adhesion molecules and receptors are of outmost
importance for the extravasation process that recruits neutrophils
from the bloodstream to inflamed or infected tissues (56), where
they exert their function in vivo. The precise role of FFA2R in the
recruitment process remains to be determined, but during this
process, the cells mobilize their granules/vesicles to expose new
receptors on the cell surface, meaning that the exudated cells are
subsequently transferred to a primed state in their response to
receptor agonists not directly involved in the extravasation pro-
cess. In contrast, exudated neutrophils are attenuated in their re-
sponse to agonists thought to be involved in the recruitment (i.e.,
the C5aR and the interleukin 8 receptor [IL-8R]) (47, 57, 58). The
functional role of FFA2R activation in inflammatory reactions is
unclear, but many danger signals attract neutrophils to sites of
infection. In accordance with this, reduced accumulation of neu-
trophils has been described to characterize the anti-infective re-
sponse in FFA2R-deficient animals, and at the same time such a
deficiency protects inflamed tissues from destruction (59). The
basic characterization of Cmp1 as a neutrophil-activating agonist
was conducted on cells isolated from peripheral blood, but it is
clear that tissue neutrophils, obtained by a skin chamber tech-
nique, behave differently in that these cells were nonresponders to
the FFA2R agonist. We know from earlier studies that the trans-
migrated neutrophils have partly mobilized their intracellular
granules and the cells express increased or decreased expression
levels of functional receptors depending on whether the receptors
are present in the granules and recruited from the stores but also
on the specific roles of the receptors in the recruitment process.
The receptors belonging to the FPR family are upregulated on
exudated neutrophils, whereasCXCR1/2, the PAFR, and theC5aR
are downregulated (58). The direct involvement of FFA2R in neu-
trophil recruitment to inflammatory sites has been shown in in-
testinal inflammation in which the receptor agonists are supposed
to have microbial origin, and in accordance with this, FFA2R
knockout mice exhibit diminished inflammation in bowel disease
models, suggesting that the receptor is involved in the recruitment
process. We now add FFA2R to the group of receptors with atten-
uated responses in neutrophils recruited to an aseptic inflamma-
tion, but we do not know whether the lack of a Cmp1 response in
tissue neutrophils means that the receptor is directly involved in
the recruitment process also in nonmicrobially related inflamma-
tion or if it is an effect of a heterologous receptor desensitization
process mediated by another receptor that is higher in the hierar-
chy than FFA2R.
It is well established that signaling through GPCRs typically
starts with a conformational change of the ligand-occupied recep-
tor and after a period of signaling, the activities are terminated and
the occupied receptor becomes refractory to further stimulation
FIG 10 Cmp1-induced neutrophil production of superoxide anions is increased in the presence of latrunculin A (LA), but desensitized FFA2Rs are not
reactivated by the drug. (A) Human neutrophils were activated with fMIFL (1 nM) in the absence or presence of latrunculin A (25 ng/ml), and superoxide
production was recorded continuously. Results of a representative experiment are shown. The time point for addition of the agonist is indicated by an arrow. (B)
Neutrophils were activated with Cmp1 (2 M) in the presence or absence of latrunculin A (25 ng/ml), and superoxide production was recorded continuously.
Results of a representative experiment are shown. The time point for addition of the agonist is indicated by an arrow. (C) Neutrophils desensitized with Cmp1
(2 M) or fMILF (1 nM) were reactivated with latrunculin A. When the initial responses (induced by Cmp1 and fMIFL, respectively; not shown) were
terminated, latrunculin A (25 ng/ml) was added (time point indicated by an arrow) and superoxide production was recorded continuously.
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with the same agonist, a process commonly termed homologous
desensitization (60, 61). One of the mechanisms suggested to in-
duce such a desensitization is receptor phosphorylation. The cur-
rently generally accepted model for termination of GPCR signal-
ing is the binding to occupied receptors of -arrestin, and this
binding is suggested to mediate homologous desensitization and
signaling termination (62). The formation of such a receptor-ar-
restin complex affects the G-protein binding interface of the re-
ceptor, which becomes sterically blocked. In contrast to most
GPCRs, the actin cytoskeleton rather than-arrestin seems to play
an important role in physical separation of agonist-occupied FPRs
from the signaling G-protein; such physical separation eventually
terminates the signaling from the occupied FPRs (43, 63, 64). The
model for how the FPRs become desensitized is very similar to this
general model, except for the involvement of actin rather than
arrestin. Actin binding physically separates the receptor from the
G-protein in the plane of the plasma membrane. Latrunculin A
disrupts the cell cytoskeleton by binding to actin polymers and
thus inhibiting their polymerization to F-actin fibers (65). The
effects of latrunculin A on the FPR1-mediated oxidase activity
fully support this model. In agreement with the suggested role of
the cytoskeleton in FPR1 termination/desensitization, neutro-
phils desensitized to the FPR1 agonist were also rapidly reacti-
vated upon addition of the actin-binding drug. A model for
Cmp1/FFA2R signaling based on the GPCR/cytoskeleton interac-
tion concept of FPRs suggests that the nonoccupied FFA2R inter-
acts more strongly with the cytoskeleton. A conformational
change in the FFA2R induced by agonist binding leads to a G-pro-
tein-coupled signaling route, resulting in a rise in intracellular
Ca2; provided that the cells have been primed, the NADPH oxi-
dase is also activated. Disruption of the cytoskeleton with latrun-
culin A prior to agonist binding would also allow for the activated
FFA2R to access the signaling route, leading to an activation of the
oxidase, and the signals generated would then be comparable to
FPR1, which is also what we found. However, in the presence of
latrunculin A, superoxide productionwas turned offmore rapidly
when induced by Cmp1 than when induced by the FPR1 agonist.
In fact, the FFA2R response in the presence of latrunculin A re-
sembled that induced by FPR1 in the absence of latrunculin A; i.e.,
also in the presence of latrunculin A the cells had an intact system
for the termination of the FFA2R-triggered response. The FPR/
cytoskeleton interaction model for termination of signaling is,
thus, not directly applicable to the FFA2R response and suggests
an alternative, non-cytoskeleton-dependent alternativemode that
is shared by the ATP/P2Y2R ligand/receptor pair (66). In accor-
dance, the nonsignaling, desensitized FFA2Rs were not reacti-
vated by a disruption of the cytoskeleton and the latrunculin A
effect was lost very rapidly after receptor activation with Cmp1.
We conclude that a non-cytoskeleton-dependent desensitization
mechanism of FFA2R is put into action promptly after agonist
binding, and we have previously shown that signaling by the neu-
trophil P2Y2R is turned off by a similar mechanism, whereas the
FPRs depend on the cytoskeleton for desensitization and termina-
tion of signaling (66).
We show that Cmp1 and CATPB function as an agonist and
antagonist for the neutrophil FFA2R, respectively, and that the
signals generated in neutrophils by the activated receptor triggered a
secretion of superoxide anions, a response largely increased in TNF-
-primed neutrophils, possibly involving amobilization of recep-
tors from the granules. Although the agonist-occupied FFA2R ac-
tivates effector functions similar to those activated by FPRs, the
regulatory mechanisms downstream of these receptors differ. The
fact that the amplifying effect of a disruption of the cytoskele-
ton is much larger for signaling by FFA2R suggests that this
receptor is partly blocked in naive cells, possibly through inter-
action of the cytosolic parts of the receptor with the actin cy-
toskeleton. Signaling by the Cmp1/FFA2R complex is also rap-
idly terminated by swift receptor desensitization, but the
mechanism for how signaling is turned off differs from that of
the FPRs. The fact that short-chain fatty acids are produced by
gut microbes during anaerobic metabolism has suggested that
receptors for such molecules expressed on innate immune cells
are of prime importance for regulating inflammatory reactions
in the gut (67), but the fact that the tissue-recruited neutrophils
were nonresponding to the FFA2R agonist suggests a role for
the receptor also in other organs and that the role of FFA2Rs is
complex and needs further analysis.
FIG 11 Cmp1-induced activation in exudated neutrophils is reduced. (A)
NADPH oxidase activity induced by fMIFL (1 nM) in peripheral blood
neutrophils and exudated neutrophils. The release of superoxide anion was
measured; curves from a representative experiment are shown together
with the mean peak values obtained from two independent experiments
(inset). The time point for addition of the agonist is indicated by an arrow.
(B) The NADPH oxidase activity induced Cmp1 (2 M) in peripheral
blood neutrophils and exudated neutrophils was assessed in the presence of
latrunculin A (25 ng/ml). The release of superoxide anion was measured;
curves from a representative experiment are shown together with the mean
peak values obtained from two independent experiments (inset). The time
point for addition of the agonist is indicated by an arrow.
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